Abvc Biopharma, Inc. (ABVC) — 10-Q Filings

10-Q Filings (6)

• ABVC BioPharma's Assets Soar 180% Amidst Widening Losses — Nov 3, 2025 Risk: high
  ABVC BioPharma, Inc. reported a significant increase in total assets to $21,176,299 as of September 30, 2025, up from $7,539,907 at December 31, 2024, primarily
• ABVC BioPharma's Assets Soar 115% Amidst Continued Losses — Aug 13, 2025 Risk: high
  ABVC BioPharma, Inc. reported a significant increase in total assets to $16,241,060 as of June 30, 2025, up from $7,539,907 at December 31, 2024, primarily driv
• ABVC BioPharma Files Q1 2025 10-Q Report — Apr 30, 2025 Risk: medium
  ABVC BioPharma, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Nevada, is based in Fremont, Cali
• ABVC BioPharma Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: low
  ABVC BioPharma, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, incorporated in Nevada, is involved in the ph
• ABVC BioPharma Files Q2 2024 10-Q Report — Aug 14, 2024 Risk: medium
  ABVC BioPharma, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, incorporated in Nevada, is based in Fremont, Calif
• ABVC BioPharma Files Q1 2024 10-Q Report — May 17, 2024 Risk: low
  ABVC BioPharma, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2024. The company, incorporated in Nevada, is involved in the pharma

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX